SummaryRecognizing and treating sleep-disordered breathing (SDB) is essential in delivering neurologic care due to its association with a growing list of neurologic conditions (e.g., stroke, neurodegenerative disorders). Thus, increased proficiency in the recognition and management of SDB is likely to result in better outcomes, care, and utilization of health care resources. To date, continuous positive airway pressure remains the gold standard for patients with moderate to severe obstructive sleep apnea and has been shown to be effective in treating variations of SDB. Appropriate application of new methods and technology such as home sleep testing can help bridge the gap between the need and supply for sleep health care and delivery. Increased focus on efficacious strategies to further awareness and education for patients, caretakers, and providers is paramount to long-term adherence to treatment. S leep-disordered breathing (SDB) is one spectrum of sleep disorders that all physicians, particularly neurologists, should have ongoing educational exposure to in order to maintain a baseline level of knowledge proficiency. Mounting evidence suggests that untreated SDB has the potential to negatively affect both patient mortality and morbidity. Untreated sleep apnea, a type of SDB, is a primary risk factor for the development of several medical conditions particularly relevant to neurologists, including hypertension, coronary heart disease, and stroke.1 SDB is not only common in neurologic patients but also may directly affect the manifestation and management of neurologic disorders.2 Thus, it is imperative that neurologists are familiar with SDB and the effect it can have on clinical practice.